Nexalin Technology (NXL) EBT Margin (QoQ) (2021 - 2026)
Powered by 
Analysis
Nexalin Technology (NXL) EBT Margin (QoQ) (2021 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 179.79 Bn | 174.18 Bn | 7.27 Bn |
| 2 | Intuitive Surgical | 127.69 Bn | 122.47 Bn | 1.96 Bn |
| 3 | Medtronic | 117.23 Bn | 108.41 Bn | 6.34 Bn |
| 4 | Stryker | 103.55 Bn | 100.07 Bn | 4.50 Bn |
| 5 | Boston Scientific | 63.24 Bn | 62.70 Bn | 3.85 Bn |
| 6 | Edwards Lifesciences | 49.97 Bn | 45.72 Bn | 1.35 Bn |
| 7 | Alcon | 32.83 Bn | 31.37 Bn | 1.68 Bn |
| 8 | Dexcom | 32.30 Bn | 30.35 Bn | 830.00 Mn |
| 9 | Steris | 20.73 Bn | 20.25 Bn | 684.20 Mn |
| 10 | Nexalin Technology | 3.44 Mn | 2.44 Mn | 8,897.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -438,705.00 |
| Mar 31, 2026 | -1.26 Mn |
| Dec 31, 2025 | 1.12 Mn |
| Sep 30, 2025 | -1.03 Mn |
| Jun 30, 2025 | 260,553.00 |
| Mar 31, 2025 | 557,996.00 |
| Dec 31, 2024 | -362,993.00 |
| Sep 30, 2024 | -201,437.00 |
| Jun 30, 2024 | -345,015.00 |
| Mar 31, 2024 | 247,068.00 |
| Dec 31, 2023 | 572,530.00 |
| Sep 30, 2023 | -721,265.00 |
| Jun 30, 2023 | 13,488.00 |
| Mar 31, 2023 | -53,114.00 |
| Dec 31, 2022 | -186,218.00 |
| Sep 30, 2022 | 5,176.00 |
| Jun 30, 2022 | 1,419.00 |
| Mar 31, 2022 | 236,151.00 |
| Dec 31, 2021 | 77,329.00 |